Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluationDominik Kraus(University of Bonn), Rainer Probstmeier(University Hospital Bonn)Cellular OncologyJune 11, 201810.1007/s13402-018-0385-5Cited by 83SaveCiteExport RISWatch citationsRelated PapersZona Pellucida Protein 2 (ZP2) Is Expressed in Colon Cancer and Promotes Cell Proliferation|Cancers|2021|11Staurosporine and Extracellular Matrix Proteins Mediate the Conversion of Small Cell Lung Carcinoma Cells into a Neuron-Like Phenotype|PLoS ONE|2014|8